Keywords: ACh; acetylcholine; AChE; acetylcholinesterase; AChEIs; acetylcholinesterase inhibitors; ASD; Autism Spectrum Disorder; BuChE; pseudocholinesterase; EDs; endocrine disruptors; PIP2; phosphatidylinositol (3,4)-bisphosphate; PIP3; phosphatidylinositol (3,4,
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 2,4-D; dichlorophenoxyacetic acid; [35S]TBPS; [35S]tertiary-butylbicyclophosphorothionate; 3-NP; 3-nitropropionic acid; 4CL; 4-coumarate: CoA ligase; 4-O-MH; 4-O-methylhonokiol; 6-OHDA; 6-hydroxydopamine; 8-oxo-dG; 8-oxo-2â²-deoxyguanosine; AChE; acetylc
Keywords: Dementia; Alzheimer disease; early treatment; AChEIs; memantine;
Keywords: OS; oxidative stress; CNS; central nervous system; ROS; reactive oxygen species; SOD; superoxide dismutase; CAT; catalase; Cu; copper; Zn; zinc; Mn; manganese; Fe; iron; Ni; nickel; DA; dopamine; PHOX; NADPH oxidase; Nrf2; nuclear factor erythroid 2-relat
Keywords: AChEIs; Small molecule; Shape-based screening; Virtual screening; Dual site inhibitor
Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine “bio-oxidizable” prodrugs: Synthesis, biological evaluation and structure-activity relationship
Keywords: AChEIs; Alzheimer; “Bio-oxidizable” prodrug; Donepezil analogues;
A hospital based epidemiological study of snakebite in Paschim Medinipur district, West Bengal, India
Keywords: RH; rural hospital; BPHC; Block Level Primary Health Centre; CMOH; Chief Medical Officer of Health; PHC; Primary Health Centre; ASV; antisnake venom; BMC; Burdwan Medical College; AchEIs; acetylcholinesterase inhibitors; Snakebite; hospital -based data; P
Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease
Keywords: AD; Alzheimer's disease; AChEIs; acetylcholinesterase inhibitors; NMDA; N-methyl-d-aspartate; Aβ; β-amyloid; Ï; tau protein; ACh; acetylcholine; MTDLs; multi-target-directed ligands; MAO-B; monoamine oxidase B; MAO-A; monoamine oxidase A; BuChE; buty
The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models
Keywords: Alzheimer's disease; APP processing/regulation; Amyloid β; Iron chelation; Propargyl moiety; AChEIs; Acetyl cholinesterase inhibitors; ADAM10; a disintegrin and metalloproteinase domain 10; Aβ; amyloid β; APP; amyloid precursor protein; APOE4; apolipop
Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells
Keywords: Cholinesterase inhibition; Monoamine oxidase-A inhibition; Multitarget drug; Scopolamine mouse model; Anti-inflammation; ACh; acetylcholine; AChE; acetylcholinesterase; AChEIs; acetylcholinesterase inhibitors; AD; Alzheimer's disease; Bcl-2; B-cell lympho
Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation
Keywords: AChEIs; acetylcholinesterase inhibitors; AD; Alzheimer's disease; ANOVA; analysis of variance; APP; amyloid precursor protein; Aβ; amyloid-β; ELISA; enzyme-linked immunosorbent assay; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; HRP; horseradish p
(â)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy
Keywords: AD; Alzheimer's disease; Aβ; amyloid-β; ACh; acetylcholine; AChE; acetylcholinesterase; AChEIs; acetylcholinesterase inhibitors; BChE; butyrylcholinesterase; BBB; blood-brain barrier; CAS; catalytic anionic site; ChEs; cholinesterases; CCK-8; cell c
Bis(9)-(â)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice
Keywords: AChE; acetylcholinesterase; AChEIs; acetylcholinesterase inhibitors; AD; Alzheimer's disease; BBB; the blood brain barrier; Bis-Mep; Bis(9)-(â)-nor-meptazinol; CAS; catalytic anionic site of AChE; PAS; peripheral anionic site of AChE; Scop; scopolamine;
DL-/PO-phosphatidylcholine may shed light on the treatment of Alzheimer dementia
Keywords: Phosphatidylcholine; Donepezil hydrochloride; Alzheimer dementia; MMSE; DL-PC; 1,2-dilinoleoyl-sn-glycero-3-phosphocholine; PO-PC; 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; MMSE; Mini-Mental State Examination; ACh; acetylcholine; AChEIs; acetylcho
Changes in cerebral glucose metabolism in patients with mild-to-moderate Alzheimer's disease: A pilot study with the Chinese herbal medicine fuzhisan
Keywords: AD; Alzheimer's disease; FZS; fuzhisan; 18F-FDG-PET; 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography; rCMRglc; regional cerebral metabolic rate of glucose consumption; ROIs; regions of interest; MRI; magnetic resonance imaging; ADAS-Cog; Alz
Antioxidant activity, acetylcholinesterase inhibition, iridoid content and mutagenic evaluation of Leucosidea sericea
Keywords: 2-AA; 2-aminoanthracene; 4NQO; 4-nitroquinoline-1-oxide; AA; antioxidant activity; AChE; acetylcholinesterase; AChEIs; acetylcholinesterase inhibitors; AD; Alzheimer's disease; ANOVA; analysis of variance; ANT; average antioxidant activity; ATCI; acetyl